Develops Engineered Micro-Pancreas (EMP) as a cell therapy solution for insulin-dependent diabetes
Betalin Therapeutics is developing the next generation of insulin-producing cell transplantation providing a solution for insulin-dependent diabetic people using tissue engineering.
Betalin developed a unique micro organ scaffold that uses natural de-cellularized ECM, derived from natural tissue, to support the long term function of β-cells.
Visit website: https://betalintherapeutics.com/
People at Betalin Therapeutics
Betalin Therapeutics News
Engineered Micro-Pancreas (EMP) could rectify diabetes
Guardian - 23-Jul-2020
Betalin's biological scaffold holds beta cells that release insulin instead of having to inject itRead more...